Commitments and Contingencies - Additional Information (Details) - USD ($)						1 Months Ended	6 Months Ended
	Apr. 07, 2023	Feb. 07, 2023	Dec. 20, 2022	Dec. 02, 2022	Apr. 03, 2019	Apr. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022
Other Commitments [Line Items]
Antibody award judgment exceeds offset		$ 50,000,000
Decrease to right-of-use assets and lease liabilities						$ 25,800,000
Scilex Holding Company
Other Commitments [Line Items]
Additional ROU assets and lease liabilities						2,500,000
San Diego, California
Other Commitments [Line Items]
Gain on derecoginization of right-of-use assets and liabilities						600,000
San Diego, California | Letters of Credit
Other Commitments [Line Items]
Issued letter of credit for rejection of leases						$ 4,100,000
Arbitrator
Other Commitments [Line Items]
Exclusive of post-award prejudgment interest percentage				9.00%
NANTibody
Other Commitments [Line Items]
Damages sought					$ 90,050,000.00
Damages sought to restore equity method investment					$ 40,000,000
NANTibody | Arbitrator
Other Commitments [Line Items]
Damages sought				$ 16,681,521
Equity interest								40.00%
Nant Pharma | Arbitrator
Other Commitments [Line Items]
Damages sought			$ 125,000,000
Amount awarded in favour of company	$ 127,686,209.93
Percentage of interest accruing	10.00%
Nant Cell Inc | Arbitrator
Other Commitments [Line Items]
Contractual damages and pre-award interest				$ 156,829,562
Accrued legal settlement amount							$ 176,600,000		$ 174,800,000
Nant Parties
Other Commitments [Line Items]
Contingency on settlement on exchange for release of company's royalty rights to PD-L1							$ 1,500,000